Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep
Clinical trial NCT04625101 · COMPLETED
Trial details
- NCT number
- NCT04625101
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-26
- Primary completion
- 2022-08-08
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.